Autism Clinical Trial
Official title:
Use of Virtual Reality Game Playing During Venipuncture
NCT number | NCT03518346 |
Other study ID # | 1170355 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | April 9, 2018 |
Est. completion date | January 15, 2019 |
Verified date | May 2019 |
Source | University of California, Davis |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To evaluate the impact of using virtual reality, VR, game playing on successful completion and reduction of distress and pain in pediatric venipuncture, and to increase adherence in obtaining the desired blood volume.
Status | Completed |
Enrollment | 12 |
Est. completion date | January 15, 2019 |
Est. primary completion date | January 15, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 8 Years to 19 Years |
Eligibility |
Inclusion Criteria: 1. Participants aged 8-19 years old that are receiving a blood draw as part of their ReCHARGE evaluation 2. History of distress or refusal of blood draws or similar medical procedures OR 3. Parent or child endorsement of fear, anxiety, concern or adherence in past blood draw during the recruitment phone call, consent or child evaluation will be offered the potential of the VR intervention OR 4. Endorsement of anxiety or concerns with medical procedures on an in house phlebotomist blood draw screening form will also be used as inclusion criteria. Exclusion Criteria: 1. History of seizures. 2. Vision loss or significant visual impairment to the degree that the participant is unable to see the activity and features of the VR game. |
Country | Name | City | State |
---|---|---|---|
United States | University of California Davis MIND Institute | Sacramento | California |
Lead Sponsor | Collaborator |
---|---|
University of California, Davis |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Attempting vs. Refusing Venipuncture | Compare if the participant is willing to let us attempt the venipuncture or refuses the venipuncture. the number of patients will be counted. | 2 years | |
Secondary | Blood volume | Volume of blood collected in mL | 2 years. Collected once on each participant: immediately following injection | |
Secondary | Pain Scale | Pain scale measures patient reports of pain levels after venipuncture on scale of 0-10 | 2 years. Collected once on each participant: immediately following injection | |
Secondary | Satisfaction Survey | Child and Parent Satisfaction Survey consists of 5 questions with likert scale responses | 2 years. Collected once on each participant: immediately following injection | |
Secondary | Fear Scale | Child Fear scale measures patient reports of fear levels before and after venipuncture on scale of 0-4 | 2 years. Collected twice on each participant: before and immediately following injection | |
Secondary | Time to Achieve Optimal Blood Volume | Time in minutes | 2 years. Collected on each participant: during venipuncture procedure |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05302167 -
Molehill Mountain Feasibility Study.
|
N/A | |
Completed |
NCT04167839 -
Effects of Sensory Diets on Children's Sensory Processing Skills, Psychosocial Skills, and Classroom Engagement
|
N/A | |
Terminated |
NCT04049981 -
Investigation of Mechanisms of Action in Superpower Glass
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT06080087 -
Implementation Toolkit to Enhance EBP Among Marginalized Families
|
N/A | |
Recruiting |
NCT04107064 -
Achieving Steady Work Among Adults With Autism Through Specialized Employment Program
|
N/A | |
Completed |
NCT03206996 -
Exposure Therapy for Auditory Sensitivity in Autism
|
N/A | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Completed |
NCT05588570 -
Coaching Children With Anxiety and Autism Through Telehealth
|
N/A | |
Enrolling by invitation |
NCT06058104 -
Evaluating Efficacy of a Digital Game Therapeutic for Children With Autism
|
N/A | |
Completed |
NCT02911194 -
a2 Milk for Autism and Attention-deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Completed |
NCT03002363 -
The Effects of Video Modeling of Audiological Testing on Pediatric Patient Compliance
|
Phase 1 | |
Completed |
NCT02847182 -
Cord Blood Infusion for Children With Autism Spectrum Disorder
|
Phase 2 | |
Withdrawn |
NCT02414451 -
Trial of Propranolol in Adults and Adolescents With ASD and Predictors of Response
|
N/A | |
Completed |
NCT02536365 -
Sensory Integration Therapy in Autism: Mechanisms and Effectiveness
|
N/A | |
Completed |
NCT02508922 -
Trial of Vitamin D3 Supplementation in Paediatric Autism
|
N/A | |
Completed |
NCT02720900 -
Prebiotic Intervention for Autism Spectrum Disorders
|
N/A | |
Completed |
NCT02708290 -
Mental Imagery Therapy for Autism (MITA) - an Early Intervention Computerized Language Training Program for Children With ASD
|
||
Recruiting |
NCT01836562 -
A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Autism
|
Phase 1/Phase 2 | |
Recruiting |
NCT02255565 -
Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study
|
Phase 4 | |
Completed |
NCT02154828 -
Clinical Evaluation of Integrative Practices Units Infant and Child Care for Unit Children With Typical or Atypical Autism (AUTISM)
|